234 related articles for article (PubMed ID: 32128997)
1. Maintaining protein stability of ∆Np63 via USP28 is required by squamous cancer cells.
Prieto-Garcia C; Hartmann O; Reissland M; Braun F; Fischer T; Walz S; Schülein-Völk C; Eilers U; Ade CP; Calzado MA; Orian A; Maric HM; Münch C; Rosenfeldt M; Eilers M; Diefenbacher ME
EMBO Mol Med; 2020 Apr; 12(4):e11101. PubMed ID: 32128997
[TBL] [Abstract][Full Text] [Related]
2. Inhibition of USP28 overcomes Cisplatin-resistance of squamous tumors by suppression of the Fanconi anemia pathway.
Prieto-Garcia C; Hartmann O; Reissland M; Fischer T; Maier CR; Rosenfeldt M; Schülein-Völk C; Klann K; Kalb R; Dikic I; Münch C; Diefenbacher ME
Cell Death Differ; 2022 Mar; 29(3):568-584. PubMed ID: 34611298
[TBL] [Abstract][Full Text] [Related]
3. USP28: Oncogene or Tumor Suppressor? A Unifying Paradigm for Squamous Cell Carcinoma.
Prieto-Garcia C; Tomašković I; Shah VJ; Dikic I; Diefenbacher M
Cells; 2021 Oct; 10(10):. PubMed ID: 34685632
[TBL] [Abstract][Full Text] [Related]
4. USP28 controls SREBP2 and the mevalonate pathway to drive tumour growth in squamous cancer.
Maier CR; Hartmann O; Prieto-Garcia C; Al-Shami KM; Schlicker L; Vogel FCE; Haid S; Klann K; Buck V; Münch C; Schmitz W; Einig E; Krenz B; Calzado MA; Eilers M; Popov N; Rosenfeldt MT; Diefenbacher ME; Schulze A
Cell Death Differ; 2023 Jul; 30(7):1710-1725. PubMed ID: 37202505
[TBL] [Abstract][Full Text] [Related]
5. USP28 enables oncogenic transformation of respiratory cells, and its inhibition potentiates molecular therapy targeting mutant EGFR, BRAF and PI3K.
Prieto-Garcia C; Hartmann O; Reissland M; Braun F; Bozkurt S; Pahor N; Fuss C; Schirbel A; Schülein-Völk C; Buchberger A; Calzado Canale MA; Rosenfeldt M; Dikic I; Münch C; Diefenbacher ME
Mol Oncol; 2022 Sep; 16(17):3082-3106. PubMed ID: 35364627
[TBL] [Abstract][Full Text] [Related]
6. ATM kinase is a master switch for the Delta Np63 alpha phosphorylation/degradation in human head and neck squamous cell carcinoma cells upon DNA damage.
Huang Y; Sen T; Nagpal J; Upadhyay S; Trink B; Ratovitski E; Sidransky D
Cell Cycle; 2008 Sep; 7(18):2846-55. PubMed ID: 18769144
[TBL] [Abstract][Full Text] [Related]
7. USP28 deletion and small-molecule inhibition destabilizes c-MYC and elicits regression of squamous cell lung carcinoma.
Ruiz EJ; Pinto-Fernandez A; Turnbull AP; Lan L; Charlton TM; Scott HC; Damianou A; Vere G; Riising EM; Da Costa C; Krajewski WW; Guerin D; Kearns JD; Ioannidis S; Katz M; McKinnon C; O'Connell J; Moncaut N; Rosewell I; Nye E; Jones N; Heride C; Gersch M; Wu M; Dinsmore CJ; Hammonds TR; Kim S; Komander D; Urbe S; Clague MJ; Kessler BM; Behrens A
Elife; 2021 Oct; 10():. PubMed ID: 34636321
[TBL] [Abstract][Full Text] [Related]
8. The deubiquitinase USP28 controls intestinal homeostasis and promotes colorectal cancer.
Diefenbacher ME; Popov N; Blake SM; Schülein-Völk C; Nye E; Spencer-Dene B; Jaenicke LA; Eilers M; Behrens A
J Clin Invest; 2014 Aug; 124(8):3407-18. PubMed ID: 24960159
[TBL] [Abstract][Full Text] [Related]
9. Dysregulation of delta Np63 alpha in squamous cell carcinoma and its therapeutic targeting.
Samanta A; Saha P; Johnson O; Bishayee A; Sinha D
Biochim Biophys Acta Rev Cancer; 2024 Jan; 1879(1):189034. PubMed ID: 38040268
[TBL] [Abstract][Full Text] [Related]
10. Dual regulation of Fbw7 function and oncogenic transformation by Usp28.
Schülein-Völk C; Wolf E; Zhu J; Xu W; Taranets L; Hellmann A; Jänicke LA; Diefenbacher ME; Behrens A; Eilers M; Popov N
Cell Rep; 2014 Nov; 9(3):1099-109. PubMed ID: 25437563
[TBL] [Abstract][Full Text] [Related]
11. USP28 promotes aerobic glycolysis of colorectal cancer by increasing stability of FOXC1.
Liu Z; Chen M; Xu X; Zhang L; Pan Y; Chen D
Acta Biochim Pol; 2021 Jun; 68(4):633-639. PubMed ID: 34106567
[TBL] [Abstract][Full Text] [Related]
12. The deubiquitinase USP28 maintains the expression of the transcription factor MYCN and is essential in neuroblastoma cells.
Li J; Peng J; Wu L; Shen X; Zhen X; Zhang Y; Ma H; Xu Y; Xiong Q; Zhu Q; Zhang P
J Biol Chem; 2023 Jul; 299(7):104856. PubMed ID: 37230388
[TBL] [Abstract][Full Text] [Related]
13. The Delta Np63 alpha phosphoprotein binds the p21 and 14-3-3 sigma promoters in vivo and has transcriptional repressor activity that is reduced by Hay-Wells syndrome-derived mutations.
Westfall MD; Mays DJ; Sniezek JC; Pietenpol JA
Mol Cell Biol; 2003 Apr; 23(7):2264-76. PubMed ID: 12640112
[TBL] [Abstract][Full Text] [Related]
14. USP28 facilitates pancreatic cancer progression through activation of Wnt/β-catenin pathway via stabilising FOXM1.
Chen L; Xu Z; Li Q; Feng Q; Zheng C; Du Y; Yuan R; Peng X
Cell Death Dis; 2021 Sep; 12(10):887. PubMed ID: 34584067
[TBL] [Abstract][Full Text] [Related]
15. Characterization of the expression pattern of p63 alpha and delta Np63 alpha in benign and malignant oral epithelial lesions.
Nylander K; Coates PJ; Hall PA
Int J Cancer; 2000 Aug; 87(3):368-72. PubMed ID: 10897041
[TBL] [Abstract][Full Text] [Related]
16. Impaired delta NP63 expression is associated with poor tumor development in transitional cell carcinoma of the bladder.
He Y; Wu X; Tang W; Tian D; Luo C; Yin Z; Du H
J Korean Med Sci; 2008 Oct; 23(5):825-32. PubMed ID: 18955789
[TBL] [Abstract][Full Text] [Related]
17. The ubiquitin-specific protease USP28 is required for MYC stability.
Popov N; Wanzel M; Madiredjo M; Zhang D; Beijersbergen R; Bernards R; Moll R; Elledge SJ; Eilers M
Nat Cell Biol; 2007 Jul; 9(7):765-74. PubMed ID: 17558397
[TBL] [Abstract][Full Text] [Related]
18. The dimeric deubiquitinase USP28 integrates 53BP1 and MYC functions to limit DNA damage.
Jin C; Einig E; Xu W; Kollampally RB; Schlosser A; Flentje M; Popov N
Nucleic Acids Res; 2024 Apr; 52(6):3011-3030. PubMed ID: 38227944
[TBL] [Abstract][Full Text] [Related]
19. USP28 promotes tumorigenesis and cisplatin resistance by deubiquitinating MAST1 protein in cancer cells.
Karapurkar JK; Colaco JC; Suresh B; Tyagi A; Woo SH; Jo WJ; Ko N; Singh V; Hong SH; Oh SJ; Kim KS; Ramakrishna S
Cell Mol Life Sci; 2024 Mar; 81(1):145. PubMed ID: 38498222
[TBL] [Abstract][Full Text] [Related]
20. Ubiquitin-specific protease 28 is overexpressed in human glioblastomas and contributes to glioma tumorigenicity by regulating MYC expression.
Wang Z; Song Q; Xue J; Zhao Y; Qin S
Exp Biol Med (Maywood); 2016 Feb; 241(3):255-64. PubMed ID: 26209720
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
